Affiliation:
1. University Institute of Engineering and Technology, Panjab University, Chandigarh, India
2. Chitkara University Institute
of Engineering and Technology, Chitkara University, Punjab, India
Abstract
Background:
With the advancement in Alzheimer's disease (AD) brain, cells start to
deteriorate, which eventually creates physical dependency and mental instability that interferes
with daily living. Presently, this disease is immedicable. Therefore, the only suitable treatment is
early detection and prevention.
Although many studies have investigated the usefulness of deep learning in AD detection, relatively
few have focused on the necessary image preprocessing processes, which are essential to
any computer-aided diagnostic system. Furthermore, an optimal classification strategy that takes
into account a diverse handful of prominent features is required.
Method:
This paper focuses on improving MRI-based AD detection by incorporating image enhancement
approaches and deep hybrid learning into a fused framework to harness the power of
multiple Deep Learning (DL) architectures and Machine Learning (ML) classifiers. The deep features
extracted from three heterogeneous CNN architectures, namely, VGG16, DensetNet169, and
MobileNetV1, are fused to produce a more informative and discriminative hybrid feature. Furthermore,
the mRMR approach was used to optimise the acquired features, followed by classification
via a stack of multiple ML classifiers to predict the target class.
Results:
The proposed architecture based on feature fusion strategy and ensemble learning resulted
in 99.53%(Accuracy), 99.73%(Precision),99.70%(Recall), and 99.72% (F1 score). The presented
model outperformed individual deep CNN architectures.
Conclusion:
Lastly, we present a sobol-based sensitivity analysis that illustrates the concentration
of the presented technique upon significant regions of the image and can assist medical professionals
in decoding the decisions. The presented technique exeplifies the potency and constancy of
categorizing Alzheimer's disease.
Publisher
Bentham Science Publishers Ltd.